Cargando…
Impact of parasite genomic dynamics on the sensitivity of Plasmodium falciparum isolates to piperaquine and other antimalarial drugs
BACKGROUND: Dihydroartemisinin-piperaquine (DHA-PPQ) is an alternative first-line antimalarial to artemether-lumefantrine in Kenya. However, recent reports on the emergence of PPQ resistance in Southeast Asia threaten its continued use in Kenya and Africa. In line with the policy on continued deploy...
Autores principales: | Wakoli, Dancan M., Ondigo, Bartholomew N., Ochora, Douglas O., Amwoma, Joseph G., Okore, Winnie, Mwakio, Edwin W., Chemwor, Gladys, Juma, Jackeline, Okoth, Raphael, Okudo, Charles, Yeda, Redemptah, Opot, Benjamin H., Cheruiyot, Agnes C., Juma, Dennis, Roth, Amanda, Ogutu, Benhards R., Boudreaux, Daniel, Andagalu, Ben, Akala, Hoseah M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673313/ https://www.ncbi.nlm.nih.gov/pubmed/36397090 http://dx.doi.org/10.1186/s12916-022-02652-2 |
Ejemplares similares
-
A seven-year surveillance of epidemiology of malaria reveals travel and gender are the key drivers of dispersion of drug resistant genotypes in Kenya
por: Maraka, Moureen, et al.
Publicado: (2020) -
Burden of malaria infection among individuals of varied blood groups in Kenya
por: Yeda, Redemptah, et al.
Publicado: (2022) -
Ex vivo and In vitro antiplasmodial activities of approved drugs predicted to have antimalarial activities using chemogenomics and drug repositioning approach
por: Ochora, Douglas O., et al.
Publicado: (2023) -
Synergism in Antiplasmodial Activities of Artemether and Lumefantrine in Combination with Securidaca longipedunculata Fresen (Polygalaceae)
por: Ochora, Douglas O., et al.
Publicado: (2021) -
Malaria Transmission Dynamics in a High-Transmission Setting of Western Kenya and the Inadequate Treatment Response to Artemether-Lumefantrine in an Asymptomatic Population
por: Andagalu, Ben, et al.
Publicado: (2022)